HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects

American Journal of Clinical Nutrition

Volumn 70, Issue 6, 1999, Pages 992-1000

  Berglund, Lars ^a   Oliver, Elizabeth H ^b   Fontanez, Nelson ^b   Holleran, Steve ^b   Matthews, Karen ^b   Roheim, Paul S ^b   Ginsberg, Henry N ^b   Ramakrishnan, Rajasekhar ^b   Lefevre, Michael ^b  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

Cardiovascular disease; Diet; HDL subpopulations; Lipoproteins; Nutrition; Race; Saturated fat; Triacylglycerols; Women

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FAT INTAKE; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LOW FAT DIET; MALE; MULTICENTER STUDY; NORMAL HUMAN; PARTICLE SIZE; PRECIPITATION; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032801362     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/70.6.992     Document Type: Article

References (60)

1. Barr DP, Russ EM, Eder HA. Protein lipid relationship in human plasma. II. In atherosclerosis and related conditions. Am J Med 1951;11:480-93.
2. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1: 16-9.
3. Gordon DJ, Rifkind BM. High density lipoprotein - the clinical implications of recent studies. N Engl J Med 1989;321:365-74.
4. Rhoads GG, Gulbrandsen CL, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 1976;294:293-8.
5. Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromso Heart Study: high-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet 1977;1:965-8.
6. Gordon DJ, Probstfield JL, Garrison RJ. High-density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:8-15.
7. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992;12:911-9.
8. Williams PT, Dreon DM, Krauss RM. Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns. Am J Clin Nutr 1995;61:1234-40.
9. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-72.
10. Schaefer EJ, Levy RI, Ernst ND Van Sant FD, Brewer HB Jr. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on plasma lipid and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects. Am J Clin Nutr 1981;34:1758-63.
11. Tall AR. Metabolic and genetic control of HDL cholesterol levels. J Intern Med 1992;231:661-8.
12. Silverman DI, Ginsburg GS, Pasternak RC. High-density lipoprotein subfractions. Am J Med 1993;94:636-45.
13. Schaefer EJ, Foster DM, Jenkins LL, Lindgren FT, Berman M, Levy RI. The composition and metabolism of high density lipoprotein subfractions. Lipids 1979;14:511-22.
14. DeLalla OF, Elliott HA, Gofman JW. Ultracentrifugal studies of high density serum lipoproteins in clinically healthy adults. Am J Physiol 1954;179:333-7.
15. Anderson DW, Nichols AV, Pan SS, Lindgren FT. High density lipoprotein distribution: resolution and determination of three major components in a normal population. Atherosclerosis 1977;29:161-79.
16. Blanche PJ, Gong EL, Forte TM, Nichols AV. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981;665:408-19.
17. Verdery RB, Benham DF, Baldwin HL, Goldberg AP, Nichols AV. Measurement of normative HDL subfraction levels by Gaussian summation analysis of gradient gels. J Lipid Res 1989;30:1085-95.
18. Li Z, McNamara JR, Ordovas JM, Schaefer EJ. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid Res 1994;35:1698-711.
19. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but not A-II. J Biol Chem 1984;259:12201-9.
20. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589-97.
21. Robinson D, Ferns GA, Bevan EA, Stocks J, Williams PT, Galton DJ. High density lipoprotein subfractions and coronary risk factors in normal men. Arteriosclerosis 1987;7:341-6.
22. Ballantyne F, Clark RS, Simpson HS, Ballantyne D. High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects. Metabolism 1982;31:433-7.
23. Hamsten A, Walldius G, Dahlen G, Johansson B, de Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis 1986;59:223-35.
24. Patsch JR, Prasad S, Gotto AM, Patsch W. High density lipoprotein 2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987;80:341-7.
25. Williams PT, Krauss RM, Vranizan KM, Stefanick ML, Wood PDS, Lindgren FT. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. Arterioscler Thromb 1992;12:332-40.
26. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 1991;325:373-81.
27. Ginsberg HN, Kris-Etherton P, Dennis B, et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol 1998;18:441-9.
28. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA 1993;269:3002-8.
29. Dennis BH, Stewart P, Wang CH, et al. Diet design for multicenter controlled feeding trials: The DELTA program. J Am Diet Assoc 1998;98:766-76.
30. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
31. Friedewald WF, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1977;18:499-502.
32. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-23.
33. NIH Consensus Conference. Triglyceride, high-density lipoprotein and coronary heart disease. JAMA 1993;269:505-10.
34. Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986;27:361-7.
35. Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984;25:1017-58.
36. Barter PJ, Hopkins GJ, Ha YC. The role of lipid transfer proteins in plasma lipoprotein metabolism. Am Heart J 1987;113:538-42.
37. Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl transfer protein gene despite increased HDL levels. J Clin Invest 1996;97:2917-23.
38. Miller NE, Hammett F, Saltissi S, et al. Relation to angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J 1981;282:1741-4.
39. 2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1043-8.
40. Wilson HM, Patel JC, Skinner ER. The distribution of high density lipoproteins in coronary survivors. Biochem Soc Trans 1991;18:1175-6.
41. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoprotein and coronary atherosclerosis: a strong relation with the largest HDL particles that is confined to normotriglyceridemic subjects. Arteriosclerosis 1991;11:174-82.
42. 2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A probucol quantitative regression Swedish trial (PQRST) report. Arterioscler Thromb Vasc Biol 1995;15:1049-56.
43. Kasim SE, Martino S, Kim PN, et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. Am J Clin Nutr 1993;57:146-53.
44. Ehnholm C, Huttunen JK, Pietinen P, et al. Effect of a diet low in unsaturated fatty acids on plasma lipids, lipoproteins and HDL subfractions. Arteriosclerosis 1984;4:265-9.
45. Shepherd J, Packer CJ, Patsch JR, Gotto AM, Taunton OD. Effects of dietary saturated and polyunsaturated fat on the properties of high density lipoproteins and the metabolism of apoprotein AI. J Clin Invest 1978;61:1582-92.
46. Clevidence BA, Judd JT, Schatzkin A, et al. Plasma lipid and lipoprotein concentrations of men consuming a low-fat, high-fiber diet. Am J Clin Nutr 1992;55:689-94.
47. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, et al. Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler Thromb Vasc Biol 1995;15:1079-85.
48. Mensink RP, Katan MP. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol on healthy women and men. N Engl J Med 1989;321:436-41.
49. Knuiman JT, West CE, Katan MB, Hautvast GAJ. Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis 1987;7: 612-9.
50. West CE, Sullivan DR, Katan MB, Halferkamps IN, van der Torre HW. Boys from populations with high-carbohydrate intake have higher fasting triglyceride levels than boys from populations with high-fat intake. Am J Epidemiol 1990;131:271-82.
51. Blum CB, Levy RI, Eisenberg S, Hall M, Goebel RH, Berman M. High density lipoprotein metabolism in man. J Clin Invest 1977;60: 795-807.
52. Brinton EA, Eisenberg S, Breslow JL. A low-fat diet decreases high density lipoprotein (HDL) cholesterol by decreasing HDL apolipoprotein transport rates. J Clin Invest 1990;85:144-51.
53. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991;88:2059-66.
54. McPherson R, Mann CJ, Tall AR, et al. Plasma concentrations of cholesteryl ester transfer protein (CETP) in hyperlipoproteinemia: relationship to CETP activity and other lipoprotein variables. Arteriosclerosis 1991;11:797-804.
55. Melish J, Le N-A, Ginsberg H, Steinberg D, Brown WV. Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. Am J Physiol 1980;239:E354-62.
56. Katan MB, Zock PL, Mensink RP. Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 1995;61(suppl): 1368S-73S.
57. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986;314: 745-8.
58. Hjermann I, Holme I, Velve Byre K, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet 1981;2:1303-10.
59. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336:129-33.
60. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339:563-9.